{"id":935,"date":"2022-07-08T14:59:00","date_gmt":"2022-07-08T06:59:00","guid":{"rendered":"https:\/\/neurotechinternational.com\/?p=935"},"modified":"2022-07-12T15:05:03","modified_gmt":"2022-07-12T07:05:03","slug":"neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022","status":"publish","type":"post","link":"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/","title":{"rendered":"Neurotech International (ASX:NTI) Webinar &#8211; Breakthrough results with NTI164 in paediatric ASD"},"content":{"rendered":"\n<figure class=\"wp-block-embed is-type-video is-provider-vimeo wp-block-embed-vimeo wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Neurotech International (ASX:NTI) Webinar - Breakthrough results with NTI164 in paediatric ASD (July 2022)\" src=\"https:\/\/player.vimeo.com\/video\/728060802?h=e98f5e5fc3&amp;dnt=1&amp;app_id=122963\" width=\"500\" height=\"281\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","_links_to":"","_links_to_target":""},"categories":[4],"tags":[43],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Neurotech International (ASX:NTI) Webinar - Breakthrough results with NTI164 in paediatric ASD &bull; Neurotech International<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neurotech International (ASX:NTI) Webinar - Breakthrough results with NTI164 in paediatric ASD &bull; Neurotech International\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Neurotech International\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-08T06:59:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-12T07:05:03+00:00\" \/>\n<meta name=\"author\" content=\"Tony Merryweather\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tony Merryweather\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/neurotechinternational.com\/#organization\",\"name\":\"Neurotech International\",\"url\":\"https:\/\/neurotechinternational.com\/\",\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/aat-research\/\"],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\/\/neurotechinternational.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/neurotechinternational.com\/wp-content\/uploads\/neurotech-international-logo.svg\",\"contentUrl\":\"https:\/\/neurotechinternational.com\/wp-content\/uploads\/neurotech-international-logo.svg\",\"width\":282,\"height\":78,\"caption\":\"Neurotech International\"},\"image\":{\"@id\":\"https:\/\/neurotechinternational.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/neurotechinternational.com\/#website\",\"url\":\"https:\/\/neurotechinternational.com\/\",\"name\":\"Neurotech International\",\"description\":\"ASX:NTI\",\"publisher\":{\"@id\":\"https:\/\/neurotechinternational.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/neurotechinternational.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-AU\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#webpage\",\"url\":\"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/\",\"name\":\"Neurotech International (ASX:NTI) Webinar - Breakthrough results with NTI164 in paediatric ASD &bull; Neurotech International\",\"isPartOf\":{\"@id\":\"https:\/\/neurotechinternational.com\/#website\"},\"datePublished\":\"2022-07-08T06:59:00+00:00\",\"dateModified\":\"2022-07-12T07:05:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#breadcrumb\"},\"inLanguage\":\"en-AU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/neurotechinternational.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neurotech International (ASX:NTI) Webinar &#8211; Breakthrough results with NTI164 in paediatric ASD\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#webpage\"},\"author\":{\"name\":\"Tony Merryweather\",\"@id\":\"https:\/\/neurotechinternational.com\/#\/schema\/person\/437747405bb2f1d488f856d887bfdb0a\"},\"headline\":\"Neurotech International (ASX:NTI) Webinar &#8211; Breakthrough results with NTI164 in paediatric ASD\",\"datePublished\":\"2022-07-08T06:59:00+00:00\",\"dateModified\":\"2022-07-12T07:05:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#webpage\"},\"wordCount\":16,\"publisher\":{\"@id\":\"https:\/\/neurotechinternational.com\/#organization\"},\"keywords\":[\"Webinar\"],\"articleSection\":[\"News &amp; Media\"],\"inLanguage\":\"en-AU\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/neurotechinternational.com\/#\/schema\/person\/437747405bb2f1d488f856d887bfdb0a\",\"name\":\"Tony Merryweather\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\/\/neurotechinternational.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/19f3d4010de384a82eece18544a72ccc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/19f3d4010de384a82eece18544a72ccc?s=96&d=mm&r=g\",\"caption\":\"Tony Merryweather\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neurotech International (ASX:NTI) Webinar - Breakthrough results with NTI164 in paediatric ASD &bull; Neurotech International","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/","og_locale":"en_US","og_type":"article","og_title":"Neurotech International (ASX:NTI) Webinar - Breakthrough results with NTI164 in paediatric ASD &bull; Neurotech International","og_url":"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/","og_site_name":"Neurotech International","article_published_time":"2022-07-08T06:59:00+00:00","article_modified_time":"2022-07-12T07:05:03+00:00","author":"Tony Merryweather","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tony Merryweather","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/neurotechinternational.com\/#organization","name":"Neurotech International","url":"https:\/\/neurotechinternational.com\/","sameAs":["https:\/\/www.linkedin.com\/company\/aat-research\/"],"logo":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/neurotechinternational.com\/#\/schema\/logo\/image\/","url":"https:\/\/neurotechinternational.com\/wp-content\/uploads\/neurotech-international-logo.svg","contentUrl":"https:\/\/neurotechinternational.com\/wp-content\/uploads\/neurotech-international-logo.svg","width":282,"height":78,"caption":"Neurotech International"},"image":{"@id":"https:\/\/neurotechinternational.com\/#\/schema\/logo\/image\/"}},{"@type":"WebSite","@id":"https:\/\/neurotechinternational.com\/#website","url":"https:\/\/neurotechinternational.com\/","name":"Neurotech International","description":"ASX:NTI","publisher":{"@id":"https:\/\/neurotechinternational.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neurotechinternational.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-AU"},{"@type":"WebPage","@id":"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#webpage","url":"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/","name":"Neurotech International (ASX:NTI) Webinar - Breakthrough results with NTI164 in paediatric ASD &bull; Neurotech International","isPartOf":{"@id":"https:\/\/neurotechinternational.com\/#website"},"datePublished":"2022-07-08T06:59:00+00:00","dateModified":"2022-07-12T07:05:03+00:00","breadcrumb":{"@id":"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#breadcrumb"},"inLanguage":"en-AU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neurotechinternational.com\/"},{"@type":"ListItem","position":2,"name":"Neurotech International (ASX:NTI) Webinar &#8211; Breakthrough results with NTI164 in paediatric ASD"}]},{"@type":"Article","@id":"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#article","isPartOf":{"@id":"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#webpage"},"author":{"name":"Tony Merryweather","@id":"https:\/\/neurotechinternational.com\/#\/schema\/person\/437747405bb2f1d488f856d887bfdb0a"},"headline":"Neurotech International (ASX:NTI) Webinar &#8211; Breakthrough results with NTI164 in paediatric ASD","datePublished":"2022-07-08T06:59:00+00:00","dateModified":"2022-07-12T07:05:03+00:00","mainEntityOfPage":{"@id":"https:\/\/neurotechinternational.com\/news-and-media\/neurotech-international-asxnti-webinar-breakthrough-results-with-nti164-in-paediatric-asd-july-2022\/#webpage"},"wordCount":16,"publisher":{"@id":"https:\/\/neurotechinternational.com\/#organization"},"keywords":["Webinar"],"articleSection":["News &amp; Media"],"inLanguage":"en-AU"},{"@type":"Person","@id":"https:\/\/neurotechinternational.com\/#\/schema\/person\/437747405bb2f1d488f856d887bfdb0a","name":"Tony Merryweather","image":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/neurotechinternational.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/19f3d4010de384a82eece18544a72ccc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/19f3d4010de384a82eece18544a72ccc?s=96&d=mm&r=g","caption":"Tony Merryweather"}}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"Tony Merryweather","author_link":"https:\/\/neurotechinternational.com\/author\/tonyadmin\/"},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"awb_sm":false,"awb_md":false,"awb_lg":false,"awb_xl":false,"sidebar-featured":false,"genesis-singular-images":false,"gb-block-post-grid-landscape":false,"gb-block-post-grid-square":false},"uagb_author_info":{"display_name":"Tony Merryweather","author_link":"https:\/\/neurotechinternational.com\/author\/tonyadmin\/"},"uagb_comment_info":0,"uagb_excerpt":null,"_links":{"self":[{"href":"https:\/\/neurotechinternational.com\/wp-json\/wp\/v2\/posts\/935"}],"collection":[{"href":"https:\/\/neurotechinternational.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neurotechinternational.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neurotechinternational.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neurotechinternational.com\/wp-json\/wp\/v2\/comments?post=935"}],"version-history":[{"count":2,"href":"https:\/\/neurotechinternational.com\/wp-json\/wp\/v2\/posts\/935\/revisions"}],"predecessor-version":[{"id":937,"href":"https:\/\/neurotechinternational.com\/wp-json\/wp\/v2\/posts\/935\/revisions\/937"}],"wp:attachment":[{"href":"https:\/\/neurotechinternational.com\/wp-json\/wp\/v2\/media?parent=935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neurotechinternational.com\/wp-json\/wp\/v2\/categories?post=935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neurotechinternational.com\/wp-json\/wp\/v2\/tags?post=935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}